NOVONIX Ltd Files 6-K with Substantial Holder Notification
Ticker: NVNXF · Form: 6-K · Filed: Oct 18, 2024 · CIK: 1859795
Sentiment: neutral
Topics: substantial-holder, filing, notification
TL;DR
NOVONIX filed a 6-K showing a substantial holder changed their stake.
AI Summary
NOVONIX Limited filed a Form 6-K on October 18, 2024, reporting for the month of October 2024. The filing includes Appendix 3G, which is a notification of change of interests of substantial holder.
Why It Matters
This filing indicates a change in a significant shareholder's stake in NOVONIX, which could signal shifts in investor confidence or strategy.
Risk Assessment
Risk Level: medium — Changes in substantial holder interests can precede significant price movements, requiring investor attention.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- Appendix 3G (document) — Included Exhibit
FAQ
What is the purpose of the Form 6-K filing by NOVONIX Limited?
The Form 6-K is a Report of Foreign Private Issuer filed for the month of October 2024, and it includes Appendix 3G, a notification of change of interests of substantial holder.
When was this Form 6-K filed?
The filing was made on October 18, 2024.
What is the Commission File Number for NOVONIX Limited?
The Commission File Number is 001-41208.
What type of document is included as Exhibit 99.1?
Exhibit 99.1 is Appendix 3G, which is a notification of change of interests of substantial holder.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Filing Stats: 203 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2024-10-18 09:21:58
Filing Documents
- nvx-6k-oct-24-10-18-app3.htm (6-K) — 18KB
- nvx-ex99_1.htm (EX-99.1) — 72KB
- img58969013_0.jpg (GRAPHIC) — 1KB
- 0000950170-24-115454.txt ( ) — 93KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: October 18, 2024